BIOMAT Database Logo BIOMAT Database Logo

Hodgkin's disease occurring in a child after liver transplantation. 1998

V Conter, and B Tschümperlin, and B Gridelli, and A Lucianetti, and S Ascani, and D Bauer, and R Burnelli, and S Poggi, and V Ramaccioni, and M Milani, and S A Pileri
Clinica Pediatrica, Ospedale S. Gerardo di Monza, University of Milan, Italy. masera@xquasar.it

Here we describe the case of a 14-year-old boy who underwent liver transplantation for post-Kasai biliary atresia when aged 4. Antirejection treatment consisted of prednisone and cyclosporine. At the age of 11 years the patient developed left cervical lymphadenopathy; the biopsy showed classical Hodgkin's disease(HD) of the mixed cellularity (MC) type. Neoplastic cells expressed CD30 and CD15, and were negative for CD45, CD20, CD3, CD43, and CD79a. Furthermore, they carried the EBV-related products LMP1 and EBER1/2. Treatment consisted of three cycles of adriamycin, bleomycin, vinblastine and DTIC (ABVD), followed by radiotherapy (2,000 cGys) on involved fields. At present, 42 months after the diagnosis of HD, the patient is still in complete remission. This is, to the best of our knowledge, the first reported case of classical HD following liver transplantation. The positivity of neoplastic cells for LMP1 and EBER1/2 indicates a possible role for immunosuppression in the development of the tumor, and whether a reduction in immunosuppression might have influenced the course of the disease is open to question.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D011878 Radiotherapy The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions. Radiotherapy, Targeted,Targeted Radiotherapy,Radiation Therapy,Radiation Therapy, Targeted,Radiation Treatment,Targeted Radiation Therapy,Radiation Therapies,Radiation Therapies, Targeted,Radiation Treatments,Radiotherapies,Radiotherapies, Targeted,Targeted Radiation Therapies,Targeted Radiotherapies,Therapies, Radiation,Therapies, Targeted Radiation,Therapy, Radiation,Therapy, Targeted Radiation,Treatment, Radiation
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D001656 Biliary Atresia Progressive destruction or the absence of all or part of the extrahepatic BILE DUCTS, resulting in the complete obstruction of BILE flow. Usually, biliary atresia is found in infants and accounts for one third of the neonatal cholestatic JAUNDICE. Atresia, Biliary,Biliary Atresia, Extrahepatic,Biliary Atresia, Intrahepatic,Extrahepatic Biliary Atresia,Familial Extrahepatic Biliary Atresia,Idiopathic Extrahepatic Biliary Atresia,Intrahepatic Biliary Atresia,Atresia, Extrahepatic Biliary,Atresia, Intrahepatic Biliary

Related Publications

V Conter, and B Tschümperlin, and B Gridelli, and A Lucianetti, and S Ascani, and D Bauer, and R Burnelli, and S Poggi, and V Ramaccioni, and M Milani, and S A Pileri
Hodgkin's disease after transplantation.
January 1996, Transplantation,
V Conter, and B Tschümperlin, and B Gridelli, and A Lucianetti, and S Ascani, and D Bauer, and R Burnelli, and S Poggi, and V Ramaccioni, and M Milani, and S A Pileri
Prolonged survival after liver transplantation for Hodgkin's disease-induced fulminant liver failure.
January 2005, Hepato-gastroenterology,
V Conter, and B Tschümperlin, and B Gridelli, and A Lucianetti, and S Ascani, and D Bauer, and R Burnelli, and S Poggi, and V Ramaccioni, and M Milani, and S A Pileri
Graft-versus-host disease after orthotopic liver transplantation in a child.
October 1990, Transplantation proceedings,
V Conter, and B Tschümperlin, and B Gridelli, and A Lucianetti, and S Ascani, and D Bauer, and R Burnelli, and S Poggi, and V Ramaccioni, and M Milani, and S A Pileri
Hodgkin's disease after renal transplantation.
April 1995, Transplantation proceedings,
V Conter, and B Tschümperlin, and B Gridelli, and A Lucianetti, and S Ascani, and D Bauer, and R Burnelli, and S Poggi, and V Ramaccioni, and M Milani, and S A Pileri
Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma.
August 1994, Blood,
V Conter, and B Tschümperlin, and B Gridelli, and A Lucianetti, and S Ascani, and D Bauer, and R Burnelli, and S Poggi, and V Ramaccioni, and M Milani, and S A Pileri
Role of hepatitis C virus in chronic liver disease occurring after orthotopic liver transplantation.
May 1995, Archives of disease in childhood,
V Conter, and B Tschümperlin, and B Gridelli, and A Lucianetti, and S Ascani, and D Bauer, and R Burnelli, and S Poggi, and V Ramaccioni, and M Milani, and S A Pileri
Burkitt's lymphoma occurring 6 years after Hodgkin's disease.
January 1980, Acta haematologica,
V Conter, and B Tschümperlin, and B Gridelli, and A Lucianetti, and S Ascani, and D Bauer, and R Burnelli, and S Poggi, and V Ramaccioni, and M Milani, and S A Pileri
Medical problems occurring after orthotopic liver transplantation.
August 1997, Digestive diseases and sciences,
V Conter, and B Tschümperlin, and B Gridelli, and A Lucianetti, and S Ascani, and D Bauer, and R Burnelli, and S Poggi, and V Ramaccioni, and M Milani, and S A Pileri
Major gastrointestinal bleeding occurring after liver transplantation.
March 1995, The Journal of the Oklahoma State Medical Association,
V Conter, and B Tschümperlin, and B Gridelli, and A Lucianetti, and S Ascani, and D Bauer, and R Burnelli, and S Poggi, and V Ramaccioni, and M Milani, and S A Pileri
Hepatopulmonary syndrome occurring after orthotopic liver transplantation.
December 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
Copied contents to your clipboard!